XML 39 R28.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2025

Stockholders' Equity

Schedule of shareholder's equity


										Accumulated
		Common		Common			Additional			Other						Total
		Stock		Stock Par			Paid-In			Comprehensive			Accumulated			Stockholders’
		Shares		Value			Capital			Income			Deficit			Equity

		(In thousands, except share amounts)
Consolidated balance at December 31, 2024		66,374,549		$	66		$	2,298,849		$	3,314		$	(1,555,224)		$	747,005
Shares issued under stock option and employee stock purchase plans		9,642			—			202			—			—			202
Stock-based compensation		—			—			9,316			—			—			9,316
Unrealized gain on marketable securities		—			—			—			254			—			254
Net loss		—			—			—			—			(53,796)			(53,796)
Consolidated balance at March 31, 2025		66,384,191		$	66		$	2,308,367		$	3,568		$	(1,609,020)		$	702,981
Shares issued under stock option and employee stock purchase plans		10,050			—			63			—			—			63
Stock-based compensation		—			—			9,191			—			—			9,191
Unrealized loss on marketable securities		—			—			—			(229)			—			(229)
Net loss		—			—			—			—			(56,600)			(56,600)
Consolidated balance at June 30, 2025		66,394,241		$	66		$	2,317,621		$	3,339		$	(1,665,620)		$	655,406
Shares issued under stock option and employee stock purchase plans		52,605			—			774			—			—			774
Stock-based compensation		—			—			8,801			—			—			8,801
Unrealized gain on marketable securities		—			—			—			426			—			426
Net loss		—			—			—			—			(67,044)			(67,044)
Consolidated balance at September 30, 2025		66,446,846		$	66		$	2,327,196		$	3,765		$	(1,732,664)		$	598,363


										Accumulated
		Common		Common			Additional			Other						Total
		Stock		Stock Par			Paid-In			Comprehensive			Accumulated			Stockholders’
		Shares		Value			Capital			Income			Deficit			Equity

		(In thousands, except share amounts)
Consolidated balance at December 31, 2023		55,883,377		$	56		$	1,823,168		$	3,308		$	(1,397,361)		$	429,171
Shares issued under stock option and employee stock purchase plans		229,171			—			3,814			—			—			3,814
Shares issued in underwritten offering, net		9,798,000			10			432,288			—			—			432,298
Stock-based compensation		—			—			7,202			—			—			7,202
Unrealized loss on marketable securities		—			—			—			(1,064)			—			(1,064)
Net loss		—			—			—			—			(32,808)			(32,808)
Consolidated balance at March 31, 2024		65,910,548		$	66		$	2,266,472		$	2,244		$	(1,430,169)		$	838,613
Shares issued under stock option and employee stock purchase plans		370,119			—			3,712			—			—			3,712
Stock-based compensation		—			—			7,640			—			—			7,640
Unrealized loss on marketable securities		—			—			—			(464)			—			(464)
Net loss		—			—			—			—			(35,842)			(35,842)
Consolidated balance at June 30, 2024		66,280,667		$	66		$	2,277,824		$	1,780		$	(1,466,011)		$	813,659
Shares issued under stock option and employee stock purchase plans		63,569			—			1,239			—			—			1,239
Stock-based compensation		—			—			9,620			—			—			9,620
Unrealized gain on marketable securities		—			—			—			3,508			—			3,508
Net loss		—			—			—			—			(42,121)			(42,121)
Consolidated balance at September 30, 2024		66,344,236		$	66		$	2,288,683		$	5,288		$	(1,508,132)		$	785,905